Welcome to the online educational program for the 2020 AABB Virtual Annual Meeting. Navigate the program using the tabs above – peruse the full program by day; use your own search term to perform a detailed search while also filtering by day, track and keyword; or dive into sessions being presented by a specific speaker.
This year, in a virtual format, sessions will be presented live and on-demand. If you opt to attend a live session, you will have the opportunity to chat with other attendees and the faculty throughout the program and participate in a live Q&A period at the conclusion of the program. In addition, there are more than 30 sessions that you can access 24 hours a day in on-demand format. To view these sessions, click the “Program Calendar” link in the top-right menu and select “On-Demand Sessions”. And if you miss a live session, it will be available on-demand within hours of the completion of the live event.
Educational Program Objectives:
The education sessions at the 2020 Annual Meeting are designed to provide insights and solutions for physicians and other health care professionals who practice in transfusion medicine and biotherapies, and to help them maintain and enhance their knowledge, skills, and abilities.
By actively participating in the continuing education programming at the 2020 Annual Meeting, physicians and other health care professionals should be able to:
-Disseminate the latest developments in laboratory, clinical, and administrative practices in transfusion medicine, patient blood management and cellular therapies.
-Foster conversations with colleagues to stimulate scientific research, enhance clinical practice and improve quality management to improve donor and patient safety in transfusion medicine and cellular therapies.
-Evaluate state of the art innovations in transfusion medicine related technologies and equipment.
– 2020 BB SBB Exam Review
– A Step Above the Basics of HLA for Apheresis Transfusion Practitioners
– Advances in Understanding of RBC Alloimmunization – Mechanisms and Interventions
– Alternatives to Apheresis Emerging Therapies
– Approaches to Pediatric Allergic Transfusion Reaction
– Are You a Group or a Team
– Ask the FDA
– Ask the Standards
– Assessment of Anemia Tolerance to Guide Transfusion Decision Making
– Assessment of New Products and Research in Neonatal and Pediatric Transfusion Protective or over-Protective
– Automated Hemovigilance Fast Healthcare Interoperability Resources (FHIR) and Big Data Analysis
– Benefit-Risk Assessment to Inform FDA Regulatory Decisions
– Big Data and Large Randomized Controlled Trials Shaping Transfusion Practices in Little People Evidence Shall Lead the Way
– Blood Bank Inspections – Staying Prepared, Handling Them, and Following up Effectively
– Breaking up in Sickle Cell Anemia Impacting Disease Pathophysiology and Transfusion Support
– Cardiac Surgery – Controversies in Blood Product Utilization, Coagulation Testing, and Perioperative Therapies
– Case Studies in Extracorporeal Life Support
– Cellular Therapies for SARS-CoV2
– Chimerism Clinical Implications for Transfusion and Transplantation
– Comparing and Contrasting Centrifuge and Membrane Therapeutic Plasma Exchange
– Complying with the ABO Second Sample in Pediatrics
– Controversies in Stem Cell Tourism Practical and Ethical Considerations
– COVID-19 Convalescent Plasma – Optimizing Collection Strategies and State of RCTs
– COVID-19 Convalescent Plasma (CCP) The Regulatory Landscape
– Delivering Next Generation Cell and Gene Therapies Toward FDA Approval for Early Stage Clinical Trials
– Desafíos Técnicos y Clínicos En El Banco De Sangre De Cordón Umbilical
– Does Assessing Vital Signs Contribute to Blood Donation Safety
– Engineered Microphysiological Systems AABB TERMIS Joint Session
– Enlightening Studies in Therapeutic Apheresis What’s Been Done, What_s Happening, and What’s to Come
– Essential Twitter for Blood Banking and Cellular Therapy Professionals
– Establishing and Applying Quality Assessments in Therapeutic Apheresis
– Evolving the Armed Services Blood Program of Today to Support the Global Transfusion Medicine Needs of Tomorrow
– Expanding Transfusion Service Models for Remote Support
– Firearm Injuries in the United States National Data and Evolution of the Transfusion Management Evidence Base
– From ABO Blood Group Determination to Immune Tolerance Induction What Is the Role of the Human Gut Microbiome
– HLA Platelet Matching Algorithms Epitope Matching Is Changing the Landscape
– Implementing the FDA Guidance for Industry of Platelets Bacterial Risk Control Strategies from a Blood Center and Transfusion Service Perspective
– Incident and Error Reporting Leveraging the Opportunities for Safer Transfusions
– Innovative Alternatives to Platelet Transfusion
– Innovative Cord Blood Derived Therapies
– Integrating the Blood Center Physician with the Blood Center Executive Team
– iPSCs for the Treatment of Beta Hemoglobinopathies
– Keeping up with the Donor History Task Force Major Changes in Blood Donor Screening
– Late-breaking Oral Abstract Session
– Make Your Transfusion Teaching Stick
– Malaria Susceptibility and Erythrocyte Antigens An Update in the Genomic Age
– Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation
– Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System
– Men Who Have Sex with Men Is Plasma Donation the Next Step
– Multidisciplinary Team Building Anesthesiology, Nursing and the Transfusion Service
– New Therapeutic Options for Patients with Sickle Cell Disease _ Their Effect on the Transfusion Service
– Oral Abstract Session COVID-19
– Oral Abstract Session Data Driven Clinical Practice
– Oral Abstract Session Donor Collection
– Oral Abstract Session New Blood Group Antigens and Novel Alleles
– Oral Abstract Session Pediatrics and Obstetrics
– Oral Abstract Session Rh Molecular and Clinical Applications
– Platelet Inventory Management for Transfusion Services
– Plenary Oral Abstract Session
– Practical Hemostasis in Transfusion Medicine Test Interpretation _ Therapeutic Strategies for Coagulation Conundrums
– Practical Tales of Red Cell Genotyping Through the Eyes of the Molecular Biologist, Serologist, and Physician
– Preparing Your Transfusion Service and Cellular Therapy Laboratory for Clinical Trials
– Recent Advances in the Practice of Pediatric Transfusion Medicine
– Rh Disease Still a Global Problem
– Searching for the Gold Standard in Patient Blood Management- Effective Means to Measure Your Successes
– Setting the Standard for Transfusion Safety One Center_s Experience Achieving Patient Based Hemovigilance
– Solve It Scenarios in Cellular Therapy
– Strategies for Mitigating Human Error in Transfusion Medicine
– Supporting Genetic Therapies for Sickle Cell Disease (ASH AABB Joint Session)
– Temas Relevantes En El Area De Medicina Transfusional y Manejo Eficiente De Los Recursos Disponibles
– Test Your Blood Bank Knowledge 2020
– The Impact on the Blood Supply of the Historic Mistrust of the Medical Establishment Among the African American Community
– The Role of Glycans in Transfusion Medicine and Disease
– The Spectrum of Pediatric Emergency Transfusion Before Arrival, in Hospital and Beyond
– The Thin Line Between Advancement or Exploitation the Role of the Super Donor in Allogeneic Cell Therapy
– Towards Personalized Hct and HbS Targets in Transfusion for Sickle Cell Disease
– Updates from the 2019 National Blood Collection and Utilization Survey (NBCUS) and Beyond
– Vector Borne Pathogens in Transfusion Medicine
– Wizardry School of Antigens and Antibodies
Release Date : October 2020
Reviews
There are no reviews yet.